No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
250 |
4. Check minimum number of eventsNone |
250 |
5. Include endpointsNone |
250 |
6. Filter based on genotype QC (FinnGen only) |
237 |
Control definitions (FinnGen only)
- Control exclude
- Q17_OTHER_CONGEN_MALFO
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Neurofibromatosis, type 1
based on the number of shared cases.
Similar with more cases:
- Phakomatoses, not elsewhere classified
- Other congenital malformations
- Other congenital malformations
- Congenital malformations, deformations and chromosomal abnormalities
- Congenital malformations, deformations and chromosomal abnormalities
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 237 | 143 | 94 |
| Unadjusted period prevalence (%) | 0.05 | 0.05 | 0.04 |
| Median age at first event (years) | 36.92 | 36.93 | 36.91 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 250
- Matched controls
- 2500
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q85.00
ICD-10 Finland
Neurofibromatosis, type 1
+∞
307.7
250
*
Q85.09
ICD-10 Finland
Unspecified neurofibromatosis
+∞
150.7
129
*
Z31.5
ICD-10 Finland
Genetic counselling
22.4
122.4
108
82
Q85.0
ICD-10 Finland
Neurofibromatosis (nonmalignant)
+∞
95.0
85
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
15.2
72.7
73
66
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
13.1
56.0
60
59
2377A
ICD-9 Finland
Neoplasm of uncertain behaviour of endocrine glands and nervous system, Neurofibromatosis
+∞
53.0
49
*
Q85.01
ICD-10 Finland
Neurofibromatosis, type 2
+∞
48.5
45
*
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
17.3
47.0
41
28
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
7.4
40.3
71
128
74340
ICD-8 Finland
Other congenital anomalies of nervous system, Neurofibromatosis
+∞
38.5
36
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
5.3
34.5
96
263
XCK00
NOMESCO Finland
Perimetry
9.0
31.2
42
55
Q85.1
ICD-10 Finland
Tuberous sclerosis
+∞
30.9
29
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
9.4
24.5
31
37
Q85.9
ICD-10 Finland
Phakomatosis, unspecified
+∞
23.3
22
*
NDR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of wrist or hand
34.5
19.7
25
8
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
17.1
18.5
29
19
ACB19
NOMESCO Finland
Excision of lesion of peripheral nerve other or unspecified
51.1
16.3
19
*
D36.1
ICD-10 Finland
Benign neoplasm: Peripheral nerves and autonomic nervous system
90.9
15.8
17
*
TQW99
NOMESCO Finland
Other minor procedure on skin
6.5
15.6
27
46
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
24.0
14.5
20
9
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.8
14.4
35
82
ZXC10
NOMESCO Finland
Use of laser
11.9
13.3
24
22
R4120
NOMESCO Finland
Occupational therapy
4.5
12.6
33
82
D33.30
ICD-10 Finland
Acoustic neuroma
31.8
11.8
15
5
XCK10
NOMESCO Finland
Photography of fundus of eye
4.0
11.4
35
98
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
4.7
10.8
26
60
QDA25
NOMESCO Finland
Destruction of lesion of skin of lower limb
114.6
10.5
11
*
L81.3
ICD-10 Finland
Café au lait spots
+∞
10.5
10
*
NK1AT
NOMESCO Finland
Muscle biopsy with ultrasound guidance
57.3
9.7
11
*
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
10.7
9.7
18
18
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.2
9.6
43
154
XA800
NOMESCO Finland
Neuropsychological investigation
4.3
9.6
26
66
Q82.50
ICD-10 Finland
Naevus flammeus
103.8
9.5
10
*
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
22.7
9.4
13
6
9736
FHL
Subcutaneous tumor removal in operating room or anesthesia
25.1
9.0
12
5
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
10.0
8.9
17
18
XCW99
NOMESCO Finland
Other investigative procedure of eye
3.5
8.9
33
105
ZXE10
NOMESCO Finland
More than one and less than three hours
2.3
8.8
97
542
WX408
NOMESCO Finland
General anesthesy, balanced
2.4
8.8
80
412
D21.1
ICD-10 Finland
Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder
28.6
8.6
11
*
SPAT1229
SPAT
Assessment of need for aid
4.9
8.5
19
41
TPH07
NOMESCO Finland
Cathetrisation of artery
3.4
8.5
33
108
ZXC07
NOMESCO Finland
Carbon dioxide laser
93.1
8.5
9
*
QBA40
NOMESCO Finland
Laser therapy or photocoagulation of skin of trunk
93.1
8.5
9
*
D33.45
ICD-10 Finland
Benign Schwannom in the nerve root of the spinal cord
93.1
8.5
9
*
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
11.3
8.4
15
14
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
10.0
8.4
16
17
QXA40
NOMESCO Finland
Skin laser treatment or photocoagulation, unspecified location
+∞
8.4
8
*
ZXD10
NOMESCO Finland
Scheduled procedure
2.2
8.2
102
595
D48.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue
9.4
8.2
16
18
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
10.6
8.1
15
15
ZXA00
NOMESCO Finland
Right side
2.4
8.0
65
316
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
4.1
7.9
22
57
NFR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of hip or thigh
46.5
7.8
9
*
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
10.5
7.6
14
14
ZXE30
NOMESCO Finland
More than five and less than seven hours
4.5
7.6
19
45
WX002
NOMESCO Finland
Sedation and analgesia
2.5
7.3
51
230
D33.46
ICD-10 Finland
Benign neurofibroma in the nerve root of the spinal cord
+∞
7.3
7
*
WX1DG
NOMESCO Finland
Very extensive total body MRI with high intensity magnet
+∞
7.3
7
*
SPAT1153
SPAT
Removal of sutures
2.2
7.3
79
433
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.8
7.2
40
161
QA4S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in face
31.0
7.2
9
*
H47.2
ICD-10 Finland
Optic atrophy
31.0
7.2
9
*
D37.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Small intestine
31.0
7.2
9
*
D23.5
ICD-10 Finland
Benign neoplasm: Skin of trunk
6.4
6.9
17
28
N03AF02
ATC
oxcarbazepine; oral
4.5
6.9
17
40
D32.00
ICD-10 Finland
Benign tumor of the meninges on the outer surface of the cerebrum
17.3
6.8
10
6
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
8.2
6.7
14
18
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
8.2
6.7
14
18
Z01.1
ICD-10 Finland
Examination of ears and hearing
2.6
6.6
41
174
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
12.7
6.6
11
9
QCA40
NOMESCO Finland
Laser therapy or photocoagulation of skin of upper limb
71.6
6.5
7
*
NA1DG
NOMESCO Finland
Cervical spine very extensive MRI examination with high intensity magnet
71.6
6.5
7
*
QCA25
NOMESCO Finland
Destruction of lesion of skin of upper limb
18.6
6.3
9
5
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
18.6
6.3
9
5
WX1CG
NOMESCO Finland
Extensive total body MRI with high intensity magnet
+∞
6.3
6
*
C72.3
ICD-10 Finland
Malignant neoplasm: Optic nerve
+∞
6.3
6
*
QAE40
NOMESCO Finland
Repair of anomaly or lesion after disease of skin of head or neck
+∞
6.3
6
*
ZXE20
NOMESCO Finland
More than three and less than five hours
2.6
6.2
39
167
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
7.0
6.1
14
21
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
44
166
3.00
8.97
6.8
12.7
-0.29
1.05
mmol/l
1.25
30
130
17
18
10.04
8.92
3.2
2.5
2.51
2.97
nmol/l
0.19
17
18
121
770
2.11
7.67
7.2
6.8
1.20
1.22
mmol/l
3.04
114
711
33
122
2.96
6.92
7.6
7.6
23.05
24.90
mmol/l
3.07
33
122
125
839
1.98
6.53
8.2
7.4
1.20
1.22
mmol/l
1.34
106
729
11
24
4.74
3.79
1.8
1.5
—
—
—
0
0
100
712
1.67
3.73
7.3
9.5
1.19
1.14
inr
0.29
34
212
6
6
10.20
3.51
5.2
3.3
64.17
41.17
nmol/l
—
6
6
73
493
1.68
3.26
3.8
3.4
0.00
0.01
estimate
0.80
22
184
13
41
3.29
3.11
2.2
1.6
—
—
—
0
0
140
1666
0.64
3.03
3.3
3.6
—
—
—
0
0
74
516
1.62
2.88
2.7
2.7
0.81
0.36
e6/l
0.35
64
376
11
33
3.44
2.85
3.8
3.2
4.67
5.10
kpa
1.07
11
33
88
642
1.57
2.82
3.1
2.9
—
—
—
0
0
11
34
3.34
2.76
1.8
1.5
—
—
—
0
0
25
127
2.08
2.71
2.6
2.4
77.25
72.40
ml/min/173m2
—
8
55
42
256
1.77
2.68
2.1
2.2
29.29
29.80
s
0.33
42
248
7
15
4.77
2.61
1.0
1.7
—
—
—
0
0
18
355
0.47
2.55
1.4
1.2
1.05
6.42
u/ml
—
6
139
112
878
1.50
2.53
2.5
2.6
—
—
—
0
0
9
26
3.55
2.50
1.7
1.5
—
—
—
0
0
19
90
2.20
2.46
1.4
1.3
—
—
—
0
0
19
90
2.20
2.46
12.6
13.6
0.63
0.70
%
0.32
19
90
28
156
1.90
2.37
4.0
3.4
—
—
—
0
0
11
39
2.90
2.37
5.7
3.4
58.00
56.74
%
0.09
11
39
11
40
2.83
2.30
1.3
1.2
—
—
—
0
0
7
20
3.57
2.07
1.9
1.5
—
—
—
0
0
10
39
2.63
1.96
1.5
2.9
3.86
4.47
e9/l
—
10
39
31
191
1.71
1.92
12.0
7.5
106.16
104.54
mmol/l
1.02
31
191
117
962
1.41
1.91
6.6
6.1
10.94
11.81
umol/l
0.35
110
914
79
606
1.44
1.89
2.7
3.1
21.99
23.68
ng/l
0.11
45
351
7
22
3.24
1.89
1.6
1.8
499.29
578.23
e6/l
—
7
22
5
12
4.23
1.83
1.2
1.6
16.15
18.28
ug/l
—
5
12
7
23
3.10
1.81
1.1
1.0
—
—
—
0
0
26
157
1.73
1.74
5.6
4.2
1.48
2.08
mmol/l
0.40
19
122
7
24
2.97
1.73
1.9
1.5
—
—
—
0
0
90
719
1.39
1.69
4.4
4.8
34.69
36.73
g/l
2.43
81
681
44
308
1.52
1.65
2.5
2.3
1.29
0.68
e6/l
0.40
25
164
5
14
3.62
1.62
1.6
1.1
—
—
—
0
0
73
567
1.41
1.61
2.3
2.5
49.82
56.43
u/l
1.12
65
534
116
973
1.36
1.60
4.9
4.3
0.00
0.01
estimate
0.50
24
185
12
57
2.16
1.57
6.3
5.7
1.24
1.31
mg/l
0.23
12
51
14
71
2.03
1.57
1.6
1.4
—
—
—
0
0
14
254
0.52
1.56
2.0
1.6
—
—
—
0
0
19
109
1.80
1.51
1.6
1.6
—
—
—
0
0
11
52
2.17
1.46
1.7
1.5
—
—
—
0
0
57
431
1.42
1.45
2.0
2.3
—
—
—
0
0
27
402
0.63
1.45
1.9
2.1
—
—
—
0
0
216
2019
1.51
1.44
17.5
12.5
139.31
139.68
mmol/l
1.15
210
1957
116
986
1.33
1.42
3.7
3.1
0.00
0.00
estimate
-0.00
25
175
30
433
0.65
1.40
2.1
2.2
—
—
—
0
0
115
978
1.33
1.40
3.8
3.1
0.00
0.00
estimate
-0.00
22
195
24
362
0.63
1.37
1.3
1.2
25.33
28.65
iu/ml
—
6
123
29
194
1.56
1.34
1.7
1.7
—
—
—
0
0
216
2026
1.49
1.34
17.5
12.6
3.93
3.94
mmol/l
0.11
209
1960
39
280
1.47
1.31
2.6
2.5
4.66
2.33
e6/l
0.95
22
137
73
588
1.34
1.27
3.0
3.3
2.36
2.36
mmol/l
0.15
66
527
6
25
2.43
1.25
1.3
1.2
—
—
—
0
0
29
198
1.53
1.24
7.0
6.2
—
—
—
0
0
6
26
2.34
1.19
1.7
1.5
—
—
—
0
0
10
50
2.04
1.18
1.8
1.5
—
—
—
0
0
28
194
1.50
1.13
1.6
1.8
—
—
—
0
0
89
751
1.29
1.09
3.7
3.1
—
—
—
0
0
37
274
1.41
1.07
1.8
1.9
—
—
—
0
0
7
34
2.09
1.03
2.1
1.4
—
—
—
0
0
7
34
2.09
1.03
2.0
2.6
26.57
24.93
mmol/l
—
7
34
5
23
2.20
0.98
1.2
1.3
—
—
—
0
0
9
50
1.83
0.97
1.1
1.5
—
—
—
0
0
8
44
1.84
0.86
1.6
2.2
—
—
—
0
0
6
31
1.96
0.85
1.2
1.1
—
—
—
0
0
158
1460
1.22
0.79
7.5
6.9
75.64
77.22
u/l
0.16
147
1369
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
16
107
1.53
0.78
1.9
2.7
8.69
5.63
ug/l
0.28
16
98
6
34
1.78
0.77
1.5
3.0
11.33
40.26
u/ml
—
6
34
10
60
1.69
0.73
1.1
1.4
466.90
406.36
mg/l
—
10
55
7
39
1.82
0.73
1.7
1.5
—
—
—
0
0
5
27
1.87
0.69
1.8
1.5
—
—
—
0
0
5
27
1.87
0.69
1.8
1.5
—
—
—
0
0
11
167
0.64
0.68
1.5
1.5
—
—
—
0
0
38
307
1.28
0.66
4.4
3.6
25.97
21.38
%
1.24
20
125
52
437
1.24
0.65
1.8
1.8
0.72
0.83
mg/l
0.20
41
341
0
20
0.00
0.60
0.0
1.8
—
—
—
0
0
0
21
0.00
0.60
0.0
3.4
—
65.94
—
0
21
0
23
0.00
0.58
0.0
1.1
—
—
—
0
0
0
23
0.00
0.58
0.0
1.1
—
—
—
0
0
5
87
0.57
0.57
1.2
1.4
—
—
—
0
0
5
87
0.57
0.57
1.2
1.4
—
—
—
0
0
5
87
0.57
0.57
1.2
1.4
—
—
—
0
0
39
323
1.25
0.56
3.4
3.1
532.61
291.89
ng/l
0.20
23
216
10
65
1.56
0.56
1.4
1.3
—
—
—
0
0
6
37
1.64
0.56
1.8
1.5
—
—
—
0
0
6
37
1.64
0.56
1.8
1.5
—
—
—
0
0
178
1861
0.85
0.53
3.4
3.4
1.19
1.26
mmol/l
0.65
158
1743
6
40
1.51
0.52
5.2
6.3
—
768.57
—
0
7
16
119
1.37
0.49
1.7
2.4
373.17
808.96
u/l
—
6
45
88
804
1.15
0.44
2.4
2.4
71.71
74.30
nmol/l
0.44
82
734
6
92
0.64
0.43
1.8
1.5
—
—
—
0
0
8
57
1.42
0.42
1.6
2.2
142.66
221.52
ug/l
—
8
49
10
70
1.45
0.42
4.8
3.0
52.88
55.70
%
—
10
70
0
15
0.00
0.41
0.0
2.6
—
—
—
0
0
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
5
35
1.44
0.39
1.0
1.3
7.66
22.90
u/l
—
5
29
5
36
1.40
0.38
1.4
1.4
—
—
—
0
0
15
116
1.31
0.38
3.5
6.2
1.71
1.33
mmol/l
—
9
92
8
115
0.69
0.38
2.8
2.0
—
—
—
0
0
10
72
1.41
0.37
1.3
1.2
—
—
—
0
0
188
1940
0.88
0.36
3.8
3.8
1.48
1.46
mmol/l
0.26
172
1823
50
559
0.87
0.36
1.5
1.6
—
—
—
0
0
26
218
1.22
0.36
2.6
2.3
27.08
24.54
%
0.26
21
190
37
323
1.17
0.34
1.7
1.6
366.37
457.38
pmol/l
2.08
27
287
19
155
1.24
0.33
1.4
4.0
2.54
38.15
ug/l
0.66
14
121
125
1186
1.11
0.32
10.0
9.1
4.53
4.01
e9/l
1.56
110
1037
11
142
0.76
0.31
1.2
1.3
—
35.77
—
0
10
10
76
1.33
0.28
7.6
2.7
0.52
0.69
%
—
10
76
11
139
0.78
0.27
1.1
1.0
—
—
—
0
0
179
1737
1.11
0.27
3.8
4.6
36.13
38.50
mmol/mol
4.30
165
1645
8
66
1.22
0.27
1.0
1.1
—
17.99
—
0
11
51
557
0.89
0.26
1.5
1.4
1.41
2.00
u/ml
0.24
15
138
6
81
0.73
0.24
1.3
1.7
—
—
—
0
0
6
84
0.71
0.24
1.5
1.3
—
—
—
0
0
5
40
1.25
0.22
1.2
1.3
—
—
—
0
0
5
40
1.25
0.22
1.2
1.3
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.6
—
8.90
—
0
10
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
12
0.00
0.21
0.0
1.8
—
852.83
—
0
12
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
5
43
1.17
0.21
1.4
1.5
—
—
—
0
0
0
13
0.00
0.21
0.0
2.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
214.19
—
0
13
0
13
0.00
0.21
0.0
1.0
—
1653.00
—
0
13
191
1949
0.92
0.20
3.8
3.8
4.73
4.72
mmol/l
0.08
176
1842
22
195
1.14
0.18
2.9
3.8
33.47
31.53
%
0.37
17
129
67
634
1.08
0.17
1.7
1.8
93.25
95.65
pmol/l
0.16
40
331
5
68
0.73
0.17
1.6
1.7
—
192.00
—
0
5
24
216
1.12
0.16
2.7
2.5
0.82
0.64
ug/l
0.61
16
122
148
1444
1.06
0.15
3.0
3.0
36.43
42.08
u/l
0.67
143
1380
42
449
0.92
0.15
3.2
3.7
5.03
9.79
mg/mmol
0.81
34
285
162
1586
1.06
0.14
4.5
3.7
14.79
14.63
pmol/l
0.38
150
1452
206
2087
0.93
0.14
14.0
11.5
26.12
22.25
mg/l
0.68
164
1555
16
142
1.14
0.13
1.5
1.3
—
—
—
0
0
22
241
0.90
0.12
1.9
2.0
—
—
—
0
0
10
85
1.18
0.12
1.6
1.8
—
—
—
0
0
5
44
1.14
0.10
13.8
4.9
3.76
3.89
mmol/l
—
5
44
221
2191
1.07
0.09
9.8
8.9
22.51
27.42
u/l
5.27
210
2122
237
2355
1.12
0.09
21.5
16.6
258.52
255.79
e9/l
0.28
229
2301
28
262
1.08
0.09
1.9
1.6
1054.73
1186.36
nmol/l
0.37
22
198
5
47
1.07
0.09
1.4
1.1
—
—
—
0
0
195
1971
0.95
0.09
4.2
4.1
2.91
2.83
mmol/l
0.58
178
1849
6
56
1.07
0.08
1.2
1.9
—
—
—
0
0
188
1859
1.05
0.08
14.3
10.0
96.62
90.49
ml/min/173m2
2.44
165
1485
5
65
0.76
0.08
1.4
1.5
—
—
—
0
0
6
73
0.82
0.07
2.8
1.8
—
—
—
0
0
8
74
1.08
0.07
1.5
1.4
—
—
—
0
0
237
2357
1.11
0.07
22.1
16.7
40.92
40.77
%
0.16
219
2230
8
93
0.86
0.07
1.3
2.0
34.57
40.71
u/l
—
8
85
9
102
0.88
0.06
1.9
1.7
—
—
—
0
0
237
2359
1.09
0.05
21.7
16.6
4.65
4.57
e12/l
1.55
229
2300
38
394
0.96
0.05
1.4
1.4
—
—
—
0
0
237
2361
1.07
0.03
21.7
16.7
136.92
136.98
g/l
0.02
232
2326
43
437
0.98
0.01
2.1
2.7
342.00
5164.09
umol/l
1.78
36
390
189
1883
1.02
0.01
5.0
4.4
1.81
1.84
mu/l
0.13
174
1754
187
1864
1.01
0.00
3.7
3.8
5.52
5.77
mmol/l
4.05
169
1729
17
171
0.99
0.00
3.8
3.6
206.47
229.72
u/l
0.51
17
165
20
203
0.98
0.00
1.6
1.9
—
—
—
0
0
52
525
0.99
0.00
1.5
1.6
1.26
1.38
mmol/l
0.61
47
449
6
67
0.89
0.00
1.5
1.9
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
99.33
—
0
6
0
7
0.00
-0.00
0.0
2.9
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
4.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
3.0
—
—
—
0
0
6
65
0.92
-0.00
1.8
2.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.9
—
—
—
0
0
6
66
0.91
-0.00
1.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
145
1450
1.00
-0.00
3.3
3.8
11.20
9.44
mm/h
0.65
133
1350
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
65
0.92
-0.00
1.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
9.86
—
0
7
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: Q17_NEUROFIBROMATOSIS_1 – Neurofibromatosis, type 1
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).